Pittenelli and Videla [82] explored the reported measured liver PPARγ mRNA levels in obese patients with steatosis and steatohepatitis, suggesting a mechanism linking liver steatosis and elevated PPARγ levels, this further increasing liver toxicities such as DILI, consistent with the findings of Rao et al. [27]. The gene discussed is PPARG; the disease is fatty liver disease.